Increasing adoption of DNA vaccines in Healthcare to Foster the Growth of the Global DNA Vaccine Market

Published: Dec 2019

The global DNA vaccine market is anticipated to grow at a considerable CAGR of around 7.6% during the forecast period (2021-2027). DNA vaccines are third-generation vaccines that are a quickly emerging vaccine platform for cancer, the major companies are aimed to develop DNA vaccine-based immunotherapeutic strategies for the treatment of infections, and cancer disease. The DNA vaccines are based on decontaminated plasmid preparations containing transgenes that encode antigenic proteins which are capable of generating an immune response to a wide range of diseases. In the terms of safety, the major factors that drive the growth of the DNA vaccines are included the DNA vaccines platform provides numerous features that convene distinct benefits above other vaccine technologies such as the ease of production and constancy, DNA vaccines have released a new approach to advance multi-antigen vaccines. Moreover, the property of specific antigen targeting developed stability, The DNA vaccines can reduce the risk of contagion as compared to conventional vaccines are projected to drive the market during the forecasted period. For Instance, In February 2019, Merck & Co., the US-based company, with d.b.a. acquired Immune Design Corporation (IDC). The company was engaged in the development of effective and safe vaccines. Through this acquisition, Merck is expected to gain access to the IDS’s various immunotherapy programs.

Browse the full report description of "Global DNA Vaccine Market Size, Share & Trends Analysis Report By Type (Animal DNA Vaccine and Human DNA Vaccine), By Technology (Plasmid DNA Vaccines Technology and Plasmid DNA Delivery Technology), By Application (Oncology, Infectious Diseases, and Others) Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/dna-vaccines-market

Additionally, according to the World Health Organization (WHO), around 18 million people mortality due to the unreachability of actual treatment for contagious diseases, which demonstrates the burden of infectious disease. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Type

o By Technology

o ByApplication

  • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape – Pfizer Inc., MERCK & CO., Sanofi Pasteur Inc., Serum Institute of India Pvt. Ltd., INOVIO Pharmaceuticals., GE healthcare life sciences, GlaxoSmithKline plc., Hoffmann-La Roche Ltd, Bharat Biotech., GC Pharma corporate

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global DNA Vaccine Market Segmentation

By Type

  • Animal DNA Vaccine
  • Human DNA Vaccine

By Technology

  • Plasmid DNA Vaccines Technology
  • Plasmid DNA Delivery Technology

By Application

  • Oncology, Infectious Diseases
  • Others

Global DNA Vaccine Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/dna-vaccines-market